FDA Approves ANDA for Verapamil Hydrochloride by Knack
The FDA has approved the ANDA220076 for Verapamil Hydrochloride submitted by Knack.
Asset / Drug
Drug and asset intelligence for Knack with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.